anthralin has been researched along with Dermatitis Medicamentosa in 27 studies
Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty patients with chronic plaque psoriasis were treated with short-contact anthralin followed by 10% triethanolamine application to one side of the body and aqueous cream to the other." | 9.06 | The effect of triethanolamine application on anthralin-induced inflammation and therapeutic effect in psoriasis. ( Bruce, JM; Lawrence, CM; Ramsay, B; Shuster, S, 1990) |
| "An open clinical trial was carried out using butantrone ointment in the treatment of 10 patients with psoriasis in order to assess staining and irritation in relation to efficacy." | 9.06 | Irritation and staining by 10-butyryl dithranol (butantrone) in psoriasis. ( Greaves, MW, 1986) |
| "5% anthralin was used to treat 51 patients with severe treatment-resistant alopecia areata." | 7.68 | Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin. ( DeVillez, RL; Fiedler, VC; Metzler, C; Szpunar, GJ; Wendrow, A, 1990) |
| "Twenty patients with chronic plaque psoriasis were treated with short-contact anthralin followed by 10% triethanolamine application to one side of the body and aqueous cream to the other." | 5.06 | The effect of triethanolamine application on anthralin-induced inflammation and therapeutic effect in psoriasis. ( Bruce, JM; Lawrence, CM; Ramsay, B; Shuster, S, 1990) |
| "An open clinical trial was carried out using butantrone ointment in the treatment of 10 patients with psoriasis in order to assess staining and irritation in relation to efficacy." | 5.06 | Irritation and staining by 10-butyryl dithranol (butantrone) in psoriasis. ( Greaves, MW, 1986) |
| "Low-dose dithranol significantly suppressed dithranol-induced oedema, whereas it had no effect on croton oil- or DNFB-induced dermatitis, suggesting that dithranol-induced tolerance is specific." | 3.71 | Low-dose dithranol treatment and tape stripping induce tolerance to dithranol in a mouse ear oedema model. ( Dobozy, A; Farkas, A; Kemény, L, 2002) |
| "Anthralin is a safe, effective treatment for psoriasis, but its efficacy is hampered by the side-effects of irritation and staining of the uninvolved skin." | 3.70 | The irritancy of anthralin is inhibited by repeat applications of a subirritant concentration. ( Friedmann, PS; Parslew, R, 1999) |
| "5% anthralin was used to treat 51 patients with severe treatment-resistant alopecia areata." | 3.68 | Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin. ( DeVillez, RL; Fiedler, VC; Metzler, C; Szpunar, GJ; Wendrow, A, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (55.56) | 18.7374 |
| 1990's | 10 (37.04) | 18.2507 |
| 2000's | 1 (3.70) | 29.6817 |
| 2010's | 1 (3.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Durdu, M | 1 |
| Özcan, D | 1 |
| Baba, M | 1 |
| Seçkin, D | 1 |
| Finnen, MJ | 1 |
| Lawrence, CM | 4 |
| Shuster, S | 5 |
| Mustakallio, KK | 1 |
| Männistö, P | 1 |
| Havas, A | 1 |
| Haasio, K | 1 |
| Hanhijärvi, H | 2 |
| Mustakallio, K | 1 |
| Howel, D | 1 |
| de Groot, AC | 1 |
| Nater, JP | 1 |
| Bleumink, E | 1 |
| de Jong, MC | 1 |
| Kersey, P | 1 |
| Chapman, P | 1 |
| Rogers, S | 1 |
| Rawlins, M | 1 |
| Lawlor, F | 1 |
| Hindson, C | 1 |
| Artemi, P | 1 |
| Land, WA | 1 |
| Burden, AD | 2 |
| Muston, H | 1 |
| Beck, MH | 2 |
| van de Kerkhof, PC | 1 |
| Ludolph-Hauser, D | 1 |
| Michelsen, S | 1 |
| Korting, HC | 1 |
| Parslew, R | 1 |
| Friedmann, PS | 1 |
| Kemény, L | 3 |
| Farkas, A | 1 |
| Dobozy, A | 3 |
| Schmoeckel, C | 1 |
| Weissmann, I | 1 |
| Plewig, G | 1 |
| Braun-Falco, O | 1 |
| Stapleton, M | 1 |
| Di Landro, A | 1 |
| Valsecchi, R | 1 |
| Cainelli, T | 1 |
| Fiedler, VC | 1 |
| Wendrow, A | 1 |
| Szpunar, GJ | 1 |
| Metzler, C | 1 |
| DeVillez, RL | 1 |
| Ramsay, B | 2 |
| Bruce, JM | 2 |
| Greaves, MW | 1 |
| Csató, M | 2 |
| Nyirádi, J | 1 |
| Gábor, M | 1 |
| Männistö, PT | 1 |
| Kosma, VM | 1 |
| Collan, Y | 1 |
| Bratzke, B | 1 |
| Albrecht, G | 1 |
| Orfanos, CE | 1 |
| Green, PG | 1 |
| Grattan, CE | 1 |
| Kennedy, CT | 1 |
| Forbes, DR | 1 |
| Schauder, S | 1 |
| Mahrle, G | 1 |
1 review available for anthralin and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Dithranol allergy: fact or fiction?
Topics: Anthralin; Coal Tar; Dermatitis, Allergic Contact; Drug Eruptions; Humans; Male; Middle Aged; Psoria | 1992 |
3 trials available for anthralin and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Inhibition of dithranol inflammation by free-radical scavengers.
Topics: Administration, Topical; Adult; Aged; Anthracenes; Anthralin; Butylated Hydroxyanisole; Diterpenes; | 1984 |
The effect of triethanolamine application on anthralin-induced inflammation and therapeutic effect in psoriasis.
Topics: Adolescent; Adult; Aged; Anthralin; Double-Blind Method; Drug Eruptions; Ethanolamines; Female; Huma | 1990 |
Irritation and staining by 10-butyryl dithranol (butantrone) in psoriasis.
Topics: Adolescent; Adult; Anthralin; Clinical Trials as Topic; Drug Eruptions; Female; Humans; Male; Middle | 1986 |
23 other studies available for anthralin and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Alopecia Areata; Anthralin; Apoptosis; CD4-CD8 R | 2015 |
Irritation and staining by dithranol (anthralin) and related compounds: II. Structure-activity relationships among 10-meso-substituted acyl analogues.
Topics: Anthracenes; Anthralin; Drug Eruptions; Edema; Erythema; Humans; Psoriasis; Skin; Structure-Activity | 1980 |
Skin irritation by dithranol (anthralin) and its 10-acyl analogues in 3 animal models.
Topics: Animals; Anthracenes; Anthralin; Dose-Response Relationship, Drug; Drug Eruptions; Female; Guinea Pi | 1984 |
The inflammatory response to anthralin.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Dose-Response Relationship, Drug; Drug Eruptions; F | 1984 |
Does DNCB therapy potentiate epicutaneous sensitization to non-related contact allergens?
Topics: Adolescent; Adult; Alopecia Areata; Anthralin; Child; Dermatitis, Contact; Dinitrochlorobenzene; Dru | 1981 |
The inflammatory response to anthralin and its relation to aryl hydrocarbon hydroxylase.
Topics: Anthracenes; Anthralin; Aryl Hydrocarbon Hydroxylases; Dermatitis, Contact; Dose-Response Relationsh | 1981 |
Allergy to dithranol.
Topics: Anthracenes; Anthralin; Dermatitis, Contact; Drug Eruptions; Female; Humans; Patch Tests; Psoriasis | 1982 |
Extemporaneous prescribing (1).
Topics: Anthralin; Dosage Forms; Drug Eruptions; Drug Prescriptions; Humans; Patient Education as Topic; Ski | 1994 |
Intolerance and contact allergy to tar and dithranol in psoriasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthralin; Coal Tar; Dermatitis, Allergic Contact; Drug | 1994 |
The Woronoff zone surrounding the psoriatic plaque.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Chronic Disease; Drug Eruptions; Femal | 1998 |
[Pustular dermatitis after administration of a too highly concentrated dithranol ointment in seborrhea].
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Dermatitis, Seborrheic; Dose-Re | 1998 |
The irritancy of anthralin is inhibited by repeat applications of a subirritant concentration.
Topics: Adaptation, Physiological; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Case-Contro | 1999 |
Low-dose dithranol treatment and tape stripping induce tolerance to dithranol in a mouse ear oedema model.
Topics: Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Croton Oil; Dinitrofluorobenz | 2002 |
Treatment of alopecia areata by anthralin-induced dermatitis.
Topics: Adolescent; Adult; Aged; Alopecia Areata; Anthracenes; Anthralin; Child; Drug Eruptions; Female; Hum | 1979 |
Contact allergy to dithranol.
Topics: Adult; Anthralin; Drug Eruptions; Humans; Male; Patch Tests; Psoriasis | 1992 |
Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin.
Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Anthralin; Child; Drug Combinations; Dr | 1990 |
Reduction of anthralin-induced inflammation by application of amines.
Topics: Administration, Cutaneous; Adult; Aged; Amines; Anthralin; Drug Eruptions; Female; Humans; Hydroxide | 1990 |
[The irritant effect of dithranol using capillary resistance measurement].
Topics: Adult; Anthralin; Clemastine; Drug Eruptions; Female; Humans; Indomethacin; Male; Middle Aged; Psori | 1989 |
Pharmacological studies on dithranol-induced irritative dermatitis in mice.
Topics: Animals; Anthralin; Clemastine; Diterpenes; Dose-Response Relationship, Drug; Drug Eruptions; Female | 1989 |
A 6-month dermal toxicity test with dithranol and butantrone in miniature swine.
Topics: Administration, Topical; Animals; Anthralin; Drug Eruptions; Drug Evaluation, Preclinical; Female; G | 1986 |
[Skin reaction to dithranol and its modification by the addition of tar (LCD)].
Topics: Anthralin; Dose-Response Relationship, Drug; Drug Eruptions; Humans; Male; Middle Aged; Patch Tests; | 1987 |
Patch testing with dithranol and its degradation products.
Topics: Anthralin; Anthraquinones; Drug Eruptions; Humans; Oxidation-Reduction; Patch Tests | 1988 |
[Effect of coal tar on cignolin erythema--1 hour treatment of psoriasis with high-dose cignolin with and without tar].
Topics: Adult; Anthracenes; Anthralin; Coal Tar; Dose-Response Relationship, Drug; Drug Combinations; Drug E | 1985 |